top of page

Team

We are a team of experts in infectious diseases, virology, molecular biology, gene therapy, regulatory management, and clinical development

Leadership

Daniel Dornbusch, MPH MBA

Chief Executive Officer

TJ Cradick, Ph.D.

Chief Scientific Officer

DSC_9597.jpg

Sara Turken, J.D.

General Counsel

Jennifer Gordon, Ph.D.

Senior Vice President, R&D

William Kennedy, M.D.

Senior Vice President, Clinical

2.png

Rose Ann Branca

Vice President, Clinical Operations

1517724414011.jpeg

Satinder Rawat, Ph.D. MBA 
Vice President Business Development

1_edited.jpg

Christine Silverstein

Chief Financial Officer

Team

DSC_0009.jpg

Panos Argiras

Senior Director, External Manufacturing

DSC_0106.jpg

Lucas Buchheim-Jurisson 

Director, Business Development & Strategy

DSC_0162.jpg

Elvin Ruan

Senior Director, Genome Editing

DSC_9451.jpg

Salvatore Amato

Senior Director, Finance

DSC_9678.jpg

Ryo Takeuchi

Director, Genome Editing

DSC_0137.jpg

Qin Xiang

Director, Analytical Development and QC

DSC_0191.jpg

Meltem Isik

Associate Director, Bioinformatics

DSC_9969.jpg

Wenwen Huo

Senior Scientist,

Bioinformatics

Sam.jpg

Sam Slattery

Senior Scientist, Nonviral Delivery

Nadia Excision.jpg

Nadia Amrani, Ph.D.

Associate Director, Genome Editing

Kevin.jpg

Kevin Luk, Ph.D.

Senior Scientist, Genome Editing

PCastillo Excision.jpg

Pamela Castillo

Senior Associate, Corporate Development

R&D Partners

Kamel Khalili, Ph.D.

Chief Scientific Founder
Temple University,
School of Medicine

Tricia Burdo, Ph.D.

Preclinical R&D
Temple University,
School of Medicine

thumbnail_Image.jpg

Ilker Sariyer, DVM Ph.D. 

Research Investigator
Temple University,
School of Medicine

Amir Khalili, M.S.

Program Manager

Temple University, School of Medicine

Board of Directors

Daniel Dornbusch, MPH MBA

Chief Executive Officer, Excision

Bill Carson, M.D.

Chairman of the Board, Otsuka Pharmaceutical Development & Commercialization, Inc.

Ashok Krishnamurthi

Managing Partner,
GreatPoint Ventures

Vasudev Bailey, Ph.D.

Partner, Artis Ventures

Jeff Kindler

Chief Executive Officer, 

Centrexion Therapeutics

Scientific Advisory Board

John Baxter, M.D.

Cooper University Medical Center

(HIV Clinician)

Toni Cathomen, Ph.D.

Albert-Ludwigs-Universitat Freiburg

(Gene Therapy)

Joseph Berger, M.D.

Perelman School of MedicineUniversity of Pennsylvania

(JC Virus & PML)

Nicole Paulk, Ph.D.

University of California San Francisco

(Oncology & AAV)

Lisa Danzig, M.D.

Life Sciences Executive 

(Global Health)

David Thomas, M.D. 
Johns Hopkins School of Medicine

(Hepatitis B) 

David Clifford, M.D.
Washington University School of Medicine in St. Louis

(PML and HIV)

Joseph Bondy-Denomy, Ph.D.
​University of California San Francisco
(CRISPR Inhibitors)

Keith Jerome, M.D., Ph.D.

Fred Hutchinson Cancer
Research Center

(Herpes Simplex Viruses, Hepatitis B)


 

Kamel Khalili, PhD

Temple University School of Medicine (Neurovirology and Gene Therapy)

Mike Walker, Ph.D.

Stanford University

(Bioinformatics)

Kenneth L. Tyler, M.D.University of Colorado Denver – Anschutz Medical Campus(JC Virus & PML)

Timothy M. Block, Ph.D. 

Baruch S. Blumberg Institute

(Hepatitis B)

 

 

Business Advisory Board

Annalisa Jenkins, M.B.B.S., F.R.C.P.

Biopharma & Life Sciences Executive

Jeff Kindler

CEO, Centrexion Therapeutics

Mark Pruzanski, M.D.​
Former CEO Intercept, Apple Tree Partners, Oak Investments

Michael Marks

Founding Managing Partner, Celesta Capital

Paul Sekhri

President and CEO, eGenesis

Sandy Zweifach
Former CEO Nuvelution Pharma, Ascendency Healthcare, Reedland Captial, Pathways Diagnostics, CFO Bay City Capital

bottom of page